BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25454831)

  • 1. Differences in pre-operative treatment for rectal cancer between Norway, Sweden, Denmark, Belgium and the Netherlands.
    van den Broek CB; van Gijn W; Bastiaannet E; Møller B; Johansson R; Elferink MA; Wibe A; Påhlman L; Iversen LH; Penninckx F; Valentini V; van de Velde CJ;
    Eur J Surg Oncol; 2014 Dec; 40(12):1789-96. PubMed ID: 25454831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.
    Breugom AJ; Bastiaannet E; Boelens PG; Van Eycken E; Iversen LH; Martling A; Johansson R; Evans T; Lawton S; O'Brien KM; Ortiz H; Janciauskiene R; Dekkers OM; Rutten HJT; Liefers GJ; Lemmens VEPP; van de Velde CJH
    Eur J Surg Oncol; 2018 Sep; 44(9):1338-1343. PubMed ID: 29960770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
    Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
    Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.
    Claassen YHM; Bastiaannet E; van Eycken E; Van Damme N; Martling A; Johansson R; Iversen LH; Ingeholm P; Lemmens VEPP; Liefers GJ; Holman FA; Dekker JWT; Portielje JEA; Rutten HJ; van de Velde CJH
    Eur J Surg Oncol; 2019 Aug; 45(8):1396-1402. PubMed ID: 31003722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative treatment selection in rectal cancer: a population-based cohort study.
    Elliot AH; Martling A; Glimelius B; Nordenvall C; Johansson H; Nilsson PJ
    Eur J Surg Oncol; 2014 Dec; 40(12):1782-8. PubMed ID: 25260598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of rectal cancer patients in Denmark during 1994-99.
    Harling H; Bülow S; Kronborg O; Møller LN; Jørgensen T;
    Colorectal Dis; 2004 May; 6(3):153-7. PubMed ID: 15109377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands.
    Elferink MA; Krijnen P; Wouters MW; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Langendijk JA; Marijnen CA; Siesling S; Tollenaar RA
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S74-82. PubMed ID: 20598844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.
    Bhangu A; Kiran RP; Audisio R; Tekkis P
    Eur J Surg Oncol; 2014 Nov; 40(11):1510-6. PubMed ID: 24704032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the treatment of rectal cancer: a population based study.
    Martling A; Granath F; Cedermark B; Johansson R; Holm T
    Eur J Surg Oncol; 2009 Apr; 35(4):427-33. PubMed ID: 18436417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison.
    Bahadoer RR; Bastiaannet E; Claassen YHM; van der Mark M; van Eycken E; Verbeeck J; Guren MG; Kørner H; Martling A; Johansson R; van de Velde CJH; Dekker JWT
    Eur J Surg Oncol; 2021 Jul; 47(7):1651-1660. PubMed ID: 33518367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in colorectal cancer treatment and survival: a cohort study covering the East Anglia region.
    Warwick J; Will O; Allgood P; Miller R; Duffy S; Greenberg D
    Colorectal Dis; 2013; 15(10):1243-52. PubMed ID: 23710604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison.
    Claassen YHM; Vermeer NCA; Iversen LH; van Eycken E; Guren MG; Mroczkowski P; Martling A; Codina Cazador A; Johansson R; Vandendael T; Wibe A; Moller B; Lippert H; Rutten HJT; Portielje JEA; Liefers GJ; Holman FA; van de Velde CJH; Bastiaannet E
    Br J Cancer; 2018 Aug; 119(4):517-522. PubMed ID: 30057408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes.
    Babaei M; Jansen L; Balavarca Y; Sjövall A; Bos A; van de Velde T; Moreau M; Liberale G; Gonçalves AF; Bento MJ; Ulrich CM; Schrotz-King P; Lemmens V; Glimelius B; Brenner H
    Clin Colorectal Cancer; 2018 Mar; 17(1):e129-e142. PubMed ID: 29074354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender aspects of survival after surgical treatment for rectal cancer.
    Lydrup ML; Höglund P
    Colorectal Dis; 2015 May; 17(5):390-6. PubMed ID: 25510408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.